Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
91 /100
CRITICAL RISK
Score updated Oct 13, 2026

SLXN — Silexion Therapeutics Corp Dilution Risk Tracker

Track SLXN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLXN — Get alerts when the score changes →

As of October 13, 2026, Silexion Therapeutics Corp (SLXN) has a DilutionWatch DilutionScore of 91/100, rated CRITICAL dilution risk. Silexion Therapeutics Corp has a market capitalization of $990.8K, 5.56M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
💰 Capital Raise model 55%
• Critical: only 2.2 months cash remaining
📉 Score Deterioration model 15%
• Score already CRITICAL (91/100) — events likely imminent
🔔 Track SLXN — Get forecast alerts →

Market Data

Market Cap$990.8K
Shares Outstanding5.56M
Float414.8K
Cash$2.23M
Debt$1.99M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore91/100DilutionWatch score record
Shares Outstanding5.56MVerified float table or market cache
Public Float414.8KVerified float table or market cache
Market Cap$990.8KMarket data cache
Cash Runway2.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, EFFECT 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

0.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SLXN for full holder detail →

Short Interest

Short Interest4.93M
Days to Cover1.0
% of Float1187.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-17
EFFECT EFFECT 2026-08-11
4 INSIDER TRANSACTION 2026-03-30
4 INSIDER TRANSACTION 2026-02-25
4 INSIDER TRANSACTION 2026-02-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SLXN Dilution Snapshot

Silexion Therapeutics Corp (SLXN) has a DilutionScore of 91/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SLXN's DilutionScore is currently 91/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 90/100 (Critical risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202691/100CRITICAL6 days
Oct 01 – Oct 07, 202690/100CRITICAL7 days
Aug 22 – Sep 30, 202698/100CRITICAL40 days
Aug 14 – Aug 21, 202690/100CRITICAL7 days
Jul 16 – Aug 13, 202698/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SLXN shares outstanding have increased 25.8% from 3.33M (Mar 2026) to 4.19M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 20264.19M4.16M▲ 0.22%
May 22, 20264.19M4.15M▲ 25.79%
Mar 28, 20263.33M3.30M▲ 4.15%
Mar 26, 20263.33M3.16M▲ 0.34%
Mar 25, 20263.33M3.15M▼ 1.16%
Mar 19, 20263.33M3.19M▲ 6.53%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SLXN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SLXN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SLXN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SLXN
SLXN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.